Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001104659-25-010561

Options or other derivatives

  • Chief Business Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kyme Pierre Chief Business Officer 2025-02-05 Grant or award · Stock Options (Right to Buy) +100,000 100,000 D: show line 1 in the form
Loading xslF345X05/tm255864-5_4seq1.xml…